Through natural language dialogue, the AI assistant automatically understands your situation and recommends appropriate prediction models
Integrates 10 clinically validated prediction models, covering the full spectrum from diagnosis to follow-up
Clear presentation of prediction results, risk stratification, and personalized treatment recommendations
Save all prediction records with support for long-term tracking and trend analysis
AI-assisted mpMRI interpretation with automatic prostate lesion segmentation and PI-RADS scoring to support biopsy decision-making
Target Population: Patients requiring MRI evaluation
Combines Prostate Health Index (PHI) with multiparametric MRI to predict clinically significant prostate cancer risk and optimize biopsy decisions
Target Population: Pre-biopsy evaluation patients
Post-diagnosis risk stratification integrating PSA, Gleason score, clinical stage, and other factors to predict 5-year disease-free survival
Target Population: Newly diagnosed patients
Predicts biochemical recurrence risk after radical prostatectomy to guide adjuvant therapy decisions
Target Population: Post-surgical patients
Competing risk framework predicting cancer-specific mortality and all-cause mortality for long-term prognosis assessment
Target Population: Post-surgical prognosis evaluation
Predicts post-radical prostatectomy urinary incontinence risk to assist pre-operative patient education and surgical planning
Target Population: Pre-operative assessment patients
Specifically designed for laparoscopic radical prostatectomy, predicting urinary continence recovery within 1 year post-surgery
Target Population: Laparoscopic surgery patients
Predicts erectile function recovery probability after nerve-sparing radical prostatectomy to support personalized surgical decision-making
Target Population: Patients concerned about sexual function preservation
Compares expected benefits and risks across radical surgery, radiation therapy, active surveillance, and other treatment options
Target Population: Patients at treatment selection stage
Predicts the risk of progression from biochemical recurrence to castration-resistant prostate cancer (CRPC) to guide subsequent treatment intensity
Target Population: Patients with biochemical recurrence
Log in to the platform with your account
Click "Start AI Consultation" to begin chatting with the AI assistant
Tell the AI assistant about your symptoms, test results, and medical history
The AI assistant recommends appropriate prediction models and presents the assessment results